title: Children with asthma on inhaled corticosteroids managed in general practice or by hospital paediatricians: is there a difference?
abstract: OBJECTIVE
  To investigate whether there are differences in asthma characteristics between two populations of children with moderate asthma requiring inhaled corticosteroids (ICS) who are treated in general practice or in hospital practice.
  
  
  METHODS
  45 children from general practice and 62 from hospital practice, diagnosed with asthma and treated with ICS, were analysed in terms of lung function parameters, asthma control (ACQ), and use of medication.
  
  
  RESULTS
  Children in general practice did not differ significantly from those in paediatric practice with respect to mean age, lung function tests, and corrected daily dose of ICS. The median ACQ score was higher (representing poorer control) in the general practice group than in the paediatric practice group (0.67 and 0.33 respectively, p < 0.05). Fewer children (22.7%) from the general practice group than from the paediatric group (98.4%) had planned review visits (p< 0.01). Prescriptions for a combination ICS/long-acting beta2-agonist (LABA) inhaler were 28.9% in the general practice group and 6.5% in the paediatric group (p<0.05).
  
  
  CONCLUSIONS
  The hospital-based group was better controlled with less frequent use of combination therapy. Our observations stress the necessity for regular review visits for children with moderately severe asthma especially in general practice.
authors.affiliation: Department of Paediatrics, Amphia Hospital, Breda, Noord Brabant, Netherlands.
authors.forename: Maarten C
authors.initials: MC
authors.lastname: Kuethe
authors.forename: Anja A
authors.initials: AA
authors.lastname: Vaessen-Verberne
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Bindels
authors.forename: Wim M
authors.initials: WM
authors.lastname: van Aalderen
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy*; D002648:Child; D005194:Family Practice / Q000706:statistics & numerical data*; D005260:Female; D005938:Glucocorticoids; D006761:Hospitals / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D009330:Nebulizers and Vaporizers / Q000706:statistics & numerical data*; D010372:Pediatrics / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011239:Prednisolone / Q000627:therapeutic use; D012129:Respiratory Function Tests; D011795:Surveys and Questionnaires
chemical_list: D000305:Adrenal Cortex Hormones; D018927:Anti-Asthmatic Agents; D005938:Glucocorticoids; D011239:Prednisolone